文献速递肿瘤 PET/CT

晚期间质性肺病患者移植肺中FAPI PET摄取与免疫组化的相关性

Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease.
PubMed 文献 · J Nucl Med · 2024-11-01

单中心、开放标签、单臂、前瞻性探索性生物分布研究初步分析,纳入4例晚期间质性肺病肺移植前接受68Ga-FAPI-46 PET/CT的患者,对3例的29份手术病理样本分析显示FAPI PET SUVmax和SUVmean与FAP免疫组化表达评分呈正相关(SUVmax r=0.57,P=0.001;SUVmean r=0.54,P=0.002)。

要点

  • 4例晚期间质性肺病患者肺移植前接受68Ga-FAPI-46 PET/CT,FAPI摄取主要见于CT上的纤维化区域。
  • 3例患者的29份手术病理样本中,FAP染色以成纤维细胞灶阳性为主。
  • FAPI PET SUVmax与FAP免疫组化评分正相关(r=0.57,P=0.001),SUVmean亦正相关(r=0.54,P=0.002)。

核心结论

  • 在FAPI PET扫描后接受肺移植的患者中,FAPI PET摄取与FAP免疫组化呈正相关。
  • 这些发现为进一步研究FAPI PET作为间质性肺病潜在影像生物标志物提供了依据。

研究设计与样本

  • 单中心、开放标签、单臂、前瞻性探索性生物分布研究的初步分析(NCT05365802)。
  • 纳入经高分辨率CT确诊并计划肺移植的间质性肺病患者,肺移植前接受68Ga-FAPI-46 PET/CT。
  • 从移植肺各肺叶的中心和周边肺实质取材,并在对应FAPI PET活性区域额外取材。
  • 用抗FAP抗体行免疫组化染色,QuPath软件半自动测量FAP免疫组化阳性面积百分比。
  • 参照移植肺大体光图在FAPI PET/CT上测量病理样本区域的SUV,采用Spearman相关系数检验FAPI PET摄取与FAP免疫组化表达的关系。

主要发现

  • 共纳入4例晚期间质性肺病患者,类型为特发性肺纤维化(n=2)、类风湿关节炎相关间质性肺病(n=1)和非特异性间质性肺炎(n=1)。
  • FAPI摄取主要显示在CT上的纤维化区域。
  • 分析了来自3例患者的29份手术病理样本,FAP染色以成纤维细胞灶阳性为主。
  • FAPI PET SUVmax与免疫组化FAP表达评分呈正相关(r=0.57,P=0.001)。
  • FAPI PET SUVmean与免疫组化FAP表达评分呈正相关(r=0.54,P=0.002)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent studies have demonstrated promising results of fibroblast activation protein (FAP) inhibitor (FAPI) PET in prognosticating and monitoring interstitial lung diseases (ILDs). As a first step toward successful translation, our primary aim was to validate the FAPI PET uptake through immunohistochemistry in patients with advanced ILD who underwent lung transplantation after a FAPI PET scan. Methods: This is a preliminary analysis of a single-center, open-label, single-arm, prospective exploratory biodistribution study of 68Ga-FAPI-46 PET imaging in patients with ILD (NCT05365802). Patients with ILD confirmed by high-resolution CT and scheduled for lung transplant were included. Tissue samples of explanted lungs were obtained from both the central and peripheral lung parenchyma of each lobe. Additional samples were obtained from areas of the lung corresponding to regions of FAPI PET activity. Immunohistochemical staining was performed with an anti-FAP antibody. Percentages of FAP immunohistochemistry-positive area were measured semiautomatically using QuPath software. SUVs in the areas of pathologic samples were measured on FAPI PET/CT by referencing the gross photomap of the explanted lung. A Spearman correlation coefficient test was used to assess the relationship between FAPI PET uptake and FAP immunohistochemical expression in each specimen. Results: Four patients with advanced ILD who underwent FAPI PET/CT before lung transplantation were included. The types of ILD were idiopathic pulmonary fibrosis (n = 2), rheumatoid arthritis-associated ILD (n = 1), and nonspecific interstitial pneumonia (n = 1). FAPI uptake was visualized mainly in the fibrotic area on CT. Twenty-nine surgical pathology samples from 3 patients were analyzed. FAP staining was predominantly positive in fibroblastic foci. FAPI PET SUVmax and SUVmean showed a positive correlation with the immunohistochemical FAP expression score (SUVmax: r = 0.57, P = 0.001; SUVmean: r = 0.54, P = 0.002). Conclusion: In this analysis conducted in patients who underwent lung transplantation after a FAPI PET scan, FAPI PET uptake was positively correlated with FAP immunohistochemistry. These findings provide a rationale for further investigation of FAPI PET as a potential imaging biomarker for ILD.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Hotta M, Kim GHJ, Rerkpichaisuth V, et al. Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease. J Nucl Med. 2024. PMID: 39362770. doi:10.2967/jnumed.124.268351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。